| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.4M | +59.1% |
| Cost of Revenue | $9.8M | +38.7% |
| Gross Profit | -$5.4M | -25.6% |
| R&D Expense | $2.0M | +40.0% |
| SG&A Expense | $10.6M | +118.2% |
| Operating Income | -$18.0M | -69.8% |
| Pre-tax Income | -$17.3M | -75.1% |
| Income Tax | $0 | — |
| Net Income | -$17.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.7M | +506.6% |
| Accounts Receivable | $686K | +161.8% |
| Inventory | $500K | +0.0% |
| Current Assets | $75.2M | — |
| Total Assets | $83.2M | — |
| Current Liabilities | $6.9M | +1552.0% |
| Total Liabilities | $10.1M | +2321.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.9M | -73.2% |
| Capital Expenditures | $1.5M | +143.2% |
| Investing Cash Flow | -$1.5M | -143.2% |
| Financing Cash Flow | $73.6M | +266.1% |
| Free Cash Flow | -$15.4M | -78.1% |
| -75.1% |
| EPS (Basic) | -$0.24 | -60.0% |
| EPS (Diluted) | -$0.24 | -60.0% |
| Stockholders' Equity |
| $73.0M |
| — |